Examination of utility of prevention and screening tests for pulmonary embolism and deep venus trombosis after total joint replacementof inferior limb.

Examination of utility of prevention and screening tests for pulmonary embolism and deep venus trombosis after total joint replacementof inferior limb. - Prevention and screening tests after totaj joint replacement.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003350

Enrollment

300

Registered

2010-04-01

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients who do total hip replacement and total knee replacement.

Interventions

We hold anticoagulant therapy with hypodermic injection of heparin in post operative all cases.heparin is chosen among three kinds at randam(Caprocin, arixtra, CLEXANE).Injections continues for two we

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The all cases which do THA or TKA in this hospital.

Exclusion criteria

Exclusion criteria: The patients who has the basal disease that anticoagulation cannot do.

Design outcomes

Primary

Measure	Time frame
Utility of screening tests(FDP D-dimer,Solible fibrine monomer complex) ,thrombotic protective effects of anticoagulation.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026